Abstract
With the emergence of nanotechnology, new methods have been developed for engineering various nanoparticles for biomedical applications. Nanotheranostics is a burgeoning research field with tremendous prospects for the improvement of diagnosis and treatment of various cancers. However, the development of biocompatible and efficient drug/gene delivery theranostic systems still remains a challenge. Green synthetic approach of nanoparticles with low capital and operating expenses, reduced environmental pollution and better biocompatibility and stability is a latest and novel field, which is advantageous over chemical or physical nanoparticle synthesis methods. In this article, we summarize the recent research progresses related to green synthesized nanoparticles for cancer theranostic applications, and we also conclude with a look at the current challenges and insight into the future directions based on recent developments in these areas.
Keywords: Green synthesis, nanoparticles, theranostics, biocompatibility, cancer, bio-imaging.
[1]
McGuire, S. World Cancer Report 2014. Geneva.; Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press. Adv. Nutr., 2015, 7(2), 418-419.
[2]
Xie, J.; Lee, S.; Chen, X. Nanoparticle-based theranostic agents. Adv. Drug Deliv. Rev., 2010, 62(11), 1064-1079.
[3]
Cassileth, B.R.; Deng, G. Complementary and alternative therapies for cancer. Oncologist, 2004, 9(1), 80-89.
[4]
Akhter, S.; Ahmad, M.Z.; Ahmad, F.J.; Storm, G.; Kok, R.J. Gold nanoparticles in theranostic oncology: current state-of-the-art. Expert Opin. Drug Deliv., 2012, 9(10), 1225-1243.
[5]
Singh, M.; Harris-Birtill, D.C.; Markar, S.R.; Hanna, G.B.; Elson, D.S. Application of gold nanoparticles for gastrointestinal cancer theranostics: A systematic review. Nanomedicine (Lond.), 2015, 11(8), 2083-2098.
[6]
Rai, P.; Mallidi, S.; Zheng, X.; Rahmanzadeh, R.; Mir, Y.; Elrington, S.; Khurshid, A.; Hasan, T. Development and applications of photo-triggered theranostic agents. Adv. Drug Deliv. Rev., 2010, 62(11), 1094-1124.
[7]
Del Vecchio, S.; Zannetti, A.; Fonti, R.; Pace, L.; Salvatore, M. Nuclear imaging in cancer theranostics. Q. J. Nucl. Med. Mol. Imaging, 2007, 51(2), 152-163.
[8]
Ma, X.; Zhao, Y.; Liang, X.J. Theranostic nanoparticles engineered for clinic and pharmaceutics. Acc. Chem. Res., 2011, 44(10), 1114-1122.
[9]
Nune, S.K.; Gunda, P.; Thallapally, P.K.; Lin, Y.Y.; Forrest, M.L.; Berkland, C.J. Nanoparticles for biomedical imaging. Expert Opin. Drug Deliv., 2009, 6(11), 1175-1194.
[10]
Arvizo, R.; Bhattacharya, R.; Mukherjee, P. Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin. Drug Deliv., 2010, 7(6), 753-763.
[11]
Talekar, M.; Kendall, J.; Denny, W.; Garg, S. Targeting of nanoparticles in cancer: drug delivery and diagnostics. Anticancer Drugs, 2011, 22(10), 949-962.
[12]
Gobbo, O.L.; Sjaastad, K.; Radomski, M.W.; Volkov, Y.; Prina-Mello, A. Magnetic Nanoparticles in Cancer Theranostics. Theranostics, 2015, 5(11), 1249-1263.
[13]
Fan, Z.; Fu, P.P.; Yu, H.; Ray, P.C. Theranostic nanomedicine for cancer detection and treatment. J. Food Drug Anal., 2014, 22(1), 3-17.
[14]
Joerger, R.; Klaus, T.; Granqvist, C.G. Biologically produced silver-carbon composite materials for optically functional thin-film coatings. Adv. Mater., 2000, 12, 407-409.
[15]
Oliveira, M.M.; Ugarte, D.; Zanchet, D.; Zarbin, A.J. Influence of synthetic parameters on the size, structure, and stability of dodecanethiol-stabilized silver nanoparticles. J. Colloid Interface Sci., 2005, 292(2), 429-435.
[16]
Panigrahi, S.; Kundu, S.; Ghosh, S.K.; Nath, S.; Pal, T. General method of synthesis for metal nanoparticles. J. Nanopart. Res., 2004, 6(4), 411-414.
[17]
Pileni, M.P. Nanosized particles made in colloidal assemblies. Langmuir, 1997, 13(13), 3266-3276.
[18]
Gan, P.P.; Ng, S.H.; Huang, Y.; Li, S.F. Green synthesis of gold nanoparticles using palm oil mill effluent (POME): a low-cost and eco-friendly viable approach. Bioresour. Technol., 2012, 113, 132-135.
[19]
Sathishkumar, M.; Sneha, K.; Won, S.W.; Cho, C.W.; Kim, S.; Yun, Y.S. Cinnamon zeylanicum bark extract and powder mediated green synthesis of nano-crystalline silver particles and its bactericidal activity. Colloids Surf. B Biointerfaces, 2009, 73(2), 332-338.
[20]
Iravani, S. Green synthesis of metal nanoparticles using plants. Green Chem., 2011, 13, 2638-2650.
[21]
Kim, J.S.; Kuk, E.; Yu, K.N.; Kim, J.H.; Park, S.J.; Lee, H.J.; Kim, S.H.; Park, Y.K.; Park, Y.H.; Hwang, C.Y.; Kim, Y.K.; Lee, Y.S.; Jeong, D.H.; Cho, M.H. Antimicrobial effects of silver nanoparticles. Nanomedicine (Lond.), 2007, 3(1), 95-101.
[22]
Alanazi, F.K.; Radwan, A.A.; Alsarra, I.A. Biopharmaceutical applications of nanogold. Saudi Pharm. J., 2010, 18(4), 179-193.
[23]
Akhtar, M.S.; Panwar, J.; Yun, Y.S. Biogenic Synthesis of Metallic Nanoparticles by Plant Extracts. ACS Sustain. Chem.& Eng., 2013, 1(6), 591-602.
[24]
Kathiresan, K.; Manivannan, S.; Nabeel, M.A.; Dhivya, B. Studies on silver nanoparticles synthesized by a marine fungus, Penicillium fellutanum isolated from coastal mangrove sediment. Colloids Surf. B Biointerfaces, 2009, 71(1), 133-137.
[25]
Song, J.Y.; Kim, B.S. Rapid biological synthesis of silver nanoparticles using plant leaf extracts. Bioprocess Biosyst. Eng., 2009, 32(1), 79-84.
[27]
Thakkar, K.N.; Mhatre, S.S.; Parikh, R.Y. Biological synthesis of metallic nanoparticles. Nanomedicine (Lond.), 2010, 6(2), 257-262.
[28]
Makarov, V.V.; Love, A.J.; Sinitsyna, O.V.; Makarova, S.S.; Yaminsky, I.V.; Taliansky, M.E.; Kalinina, N.O. “Green” nanotechnologies: synthesis of metal nanoparticles using plants. Acta Naturae, 2014, 6(1), 35-44.
[30]
Rajasekharreddy, P.; Rani, P.U. Biofabrication of Ag nanoparticles using Sterculia foetida L. seed extract and their toxic potential against mosquito vectors and HeLa cancer cells. Mater. Sci. Eng. C, 2014, 39(1), 203-212.
[31]
Shah, M.; Fawcett, D.; Sharma, S.; Tripathy, S.K.; Poinern, G.E.J. Green Synthesis of Metallic Nanoparticles via Biological Entities. Materials (Basel), 2015, 8(11), 7278-7308.
[32]
Patra, S.; Mukherjee, S.; Barui, A.K.; Ganguly, A.; Sreedhar, B.; Patra, C.R. Green synthesis, characterization of gold and silver nanoparticles and their potential application for cancer therapeutics. Mater. Sci. Eng. C, 2015, 53, 298-309.
[33]
Sankar, R.; Karthik, A.; Prabu, A.; Karthik, S.; Shivashangari, K.S.; Ravikumar, V. Origanum vulgare mediated biosynthesis of silver nanoparticles for its antibacterial and anticancer activity. Colloids Surf. B Biointerfaces, 2013, 108, 80-84.
[34]
Mata, R.; Nakkala, J.R.; Sadras, S.R. Biogenic silver nanoparticles from Abutilon indicum: their antioxidant, antibacterial and cytotoxic effects in vitro. Colloids Surf. B Biointerfaces, 2015, 128, 276-286.
[35]
Nayak, D.; Pradhan, S.; Ashe, S.; Rauta, P.R.; Nayak, B. Biologically synthesised silver nanoparticles from three diverse family of plant extracts and their anticancer activity against epidermoid A431 carcinoma. J. Colloid Interface Sci., 2015, 457, 329-338.
[36]
Sathishkumar, P.; Preethi, J.; Vijayan, R.; Mohd Yusoff, A.R.; Ameen, F.; Suresh, S.; Balagurunathan, R.; Palvannan, T. Anti-acne, anti-dandruff and anti-breast cancer efficacy of green synthesised silver nanoparticles using Coriandrum sativum leaf extract. J. Photochem. Photobiol. B, 2016, 163, 69-76.
[37]
Leela, A.; Vivekanandan, M. Tapping the unexploited plant resources for the synthesis of silver nanoparticles. Afr. J. Biotechnol., 2008, 7, 3162-3165.
[38]
Devi, S.J.; Bhimba, B.V. Anticancer activity of silver nanoparticles synthesized by the seaweed ulva lactuca in vitro. Sci. Rep., 2012, 1, 242.
[39]
Gurunathan, S.; Han, J.W.; Eppakayala, V.; Kim, J.H. Green synthesis of graphene and its cytotoxic effects in human breast cancer cells. Int. J. Nanomedicine, 2013, 8, 1015-1027.
[40]
Mukherjee, S.; Chowdhury, D.; Kotcherlakota, R.; Patra, S.B.V.; Bhadra, M.P.; Sreedhar, B.; Patra, C.R. Potential theranostics application of bio-synthesized silver nanoparticles (4-in-1 system). Theranostics, 2014, 4(3), 316-335.
[41]
Piao, M.J.; Kang, K.A.; Lee, I.K.; Kim, H.S.; Kim, S.; Choi, J.Y.; Choi, J.; Hyun, J.W. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol. Lett., 2011, 201(1), 92-100.
[42]
Gao, S.; Chen, D.; Li, Q.; Ye, J.; Jiang, H.; Amatore, C.; Wang, X. Near-infrared fluorescence imaging of cancer cells and tumors through specific biosynthesis of silver nanoclusters. Sci. Rep., 2014, 4, 4384.
[43]
Yarramala, D.S.; Doshi, S.; Rao, C.P. Green synthesis, characterization and anticancer activity of luminescent gold nanoparticles capped with apo-alpha-lactalbumin. RSC Advances, 2015, 5, 32761-32767.
[44]
Mukherjee, S.; Ghosh, S.; Das, D.K.; Chakraborty, P.; Choudhury, S.; Gupta, P.; Adhikary, A.; Dey, S.; Chattopadhyay, S. Gold-conjugated green tea nanoparticles for enhanced anti-tumor activities and hepatoprotection--synthesis, characterization and in vitro evaluation. J. Nutr. Biochem., 2015, 26(11), 1283-1297.
[45]
Vijayakumar, S.; Vaseeharan, B.; Malaikozhundan, B.; Gopi, N.; Ekambaram, P.; Pachaiappan, R.; Velusamy, P.; Murugan, K.; Benelli, G.; Suresh Kumar, R.; Suriyanarayanamoorthy, M. Therapeutic effects of gold nanoparticles synthesized using Musa paradisiaca peel extract against multiple antibiotic resistant Enterococcus faecalis biofilms and human lung cancer cells (A549). Microb. Pathog., 2017, 102, 173-183.
[46]
Kumar, S.A.; Peter, Y.A.; Nadeau, J.L. Facile biosynthesis, separation and conjugation of gold nanoparticles to doxorubicin. Nanotechnology, 2008, 19(49), 495101.
[47]
Chauhan, A.; Zubair, S.; Tufail, S.; Sherwani, A.; Sajid, M.; Raman, S.C.; Azam, A.; Owais, M. Fungus-mediated biological synthesis of gold nanoparticles: potential in detection of liver cancer. Int. J. Nanomedicine, 2011, 6, 2305-2319.
[48]
Wang, J.; Zhang, G.; Li, Q.; Jiang, H.; Liu, C.; Amatore, C.; Wang, X. In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters. Sci. Rep., 2013, 3, 1157.
[49]
Fazal, S.; Jayasree, A.; Sasidharan, S.; Koyakutty, M.; Nair, S.V.; Menon, D. Green synthesis of anisotropic gold nanoparticles for photothermal therapy of cancer. ACS Appl. Mater. Interfaces, 2014, 6(11), 8080-8089.
[50]
Tan, A.; Yildirimer, L.; Rajadas, J.; De La Peña, H.; Pastorin, G.; Seifalian, A. Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine (Lond.), 2011, 6(6), 1101-1114.
[51]
Yue, X.U.; Tang, C.J.; Huang, H.; Sun, C.Q.; Zhang, Y.K.; Ye, Q.F.; Wang, A.J. Green Synthesis of Fluorescent Carbon Quantum Dots for Detection of Hg2+. Chin. J. Anal. Chem., 2014, 42(9), 1252-1258.
[52]
Lee, H.U.; Park, S.Y.; Park, E.S.; Son, B.; Lee, S.C.; Lee, J.W.; Lee, Y.C.; Kang, K.S.; Kim, M.I.; Park, H.G.; Choi, S.; Huh, Y.S.; Lee, S.Y.; Lee, K.B.; Oh, Y.K.; Lee, J. Photoluminescent carbon nanotags from harmful cyanobacteria for drug delivery and imaging in cancer cells. Sci. Rep., 2014, 4, 4665.
[53]
Sonkurse, P.; Nanduri, R.; Gupta, P. Improve extraction of intracellular biogenic selenium nanoparticles and their specificity for cancer chemo prevention. J. Nanomed. Nanotechnol., 2014, 5, 194.
[54]
Sharma, G.; Sharma, A.R.; Bhavesh, R.; Park, J.; Ganbold, B.; Nam, J.S.; Lee, S.S. Biomolecule-mediated synthesis of selenium nanoparticles using dried Vitis vinifera (raisin) extract. Molecules, 2014, 19(3), 2761-2770.
[55]
Ramamurthy, Ch.; Sampath, K.S.; Arunkumar, P.; Kumar, M.S.; Sujatha, V.; Premkumar, K.; Thirunavukkarasu, C. Green synthesis and characterization of selenium nanoparticles and its augmented cytotoxicity with doxorubicin on cancer cells. Bioprocess Biosyst. Eng., 2013, 36(8), 1131-1139.
[56]
Vijayakumar, S.; Vaseeharan, B.; Malaikozhundan, B.; Shobiya, M. Laurus nobilis leaf extract mediated green synthesis of ZnO nanoparticles: Characterization and biomedical applications. Biomed. Pharmacother., 2016, 84, 1213-1222.
[57]
Padalia, H.; Chanda, S. Characterization, antifungal and cytotoxic evaluation of green synthesized zinc oxide nanoparticles using Ziziphus nummularia leaf extract. Artif. Cells Nanomed. Biotechnol., 2017, 45(8), 1751-1761.
[58]
Anand, K.; Tiloke, C.; Phulukdaree, A.; Ranjan, B.; Chuturgoon, A.; Singh, S.; Gengan, R.M. Biosynthesis of palladium nanoparticles by using Moringa oleifera flower extract and their catalytic and biological properties. J. Photochem. Photobiol. B, 2016, 165, 87-95.
[59]
Sivaraj, R.; Rahman, P.K.; Rajiv, P.; Narendhran, S.; Venckatesh, R. Biosynthesis and characterization of Acalypha indica mediated copper oxide nanoparticles and evaluation of its antimicrobial and anticancer activity. Spectrochim. Acta A Mol. Biomol. Spectrosc., 2014, 129, 255-258.
[60]
Alshatwi, A.A.; Athinarayanan, J.; Vaiyapuri Subbarayan, P. Green synthesis of platinum nanoparticles that induce cell death and G2/M-phase cell cycle arrest in human cervical cancer cells. J. Mater. Sci. Mater. Med., 2015, 26(1), 5330.
[61]
Song, X.R.; Yu, S.X.; Jin, G.X.; Wang, X.; Chen, J.; Li, J.; Liu, G.; Yang, H.H. Plant Polyphenol-Assisted Green Synthesis of Hollow CoPt Alloy Nanoparticles for Dual-Modality Imaging Guided Photothermal Therapy. Small, 2016, 12(11), 1506-1513.
[62]
Ambrogio, M.W.; Thomas, C.R.; Zhao, Y.L.; Zink, J.I.; Stoddart, J.F. Mechanized silica nanoparticles: a new frontier in theranostic nanomedicine. Acc. Chem. Res., 2011, 44(10), 903-913.
[63]
Kordezangeneh, M.; Irani, S.; Mirfakhraie, R.; Esfandyari-Manesh, M.; Atyabi, F.; Dinarvand, R. Regulation of BAX/BCL2 gene expression in breast cancer cells by docetaxel-loaded human serum albumin nanoparticles. Med. Oncol., 2015, 32(7), 208.
[64]
Min, S.Y.; Byeon, H.J.; Lee, C.; Seo, J.; Lee, E.S.; Shin, B.S.; Choi, H.G.; Lee, K.C.; Youn, Y.S. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer. Int. J. Pharm., 2015, 494(1), 506-515.
[65]
Yin, T.; Dong, L.; Cui, B.; Wang, L.; Yin, L.; Zhou, J.; Huo, M. A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy. Int. J. Nanomedicine, 2015, 10(1), 7397-7412.
[66]
Byeon, H.J.; Thao, Q.; Lee, S.; Min, S.Y.; Lee, E.S.; Shin, B.S.; Choi, H.G.; Youn, Y.S. Doxorubicin-loaded nanoparticles consisted of cationic- and mannose-modified-albumins for dual-targeting in brain tumors. J. Control. Release, 2016, 225, 301-313.
[67]
Thao, Q.; Byeon, H.J.; Lee, C.; Lee, S.; Lee, E.S.; Choi, Y.W.; Choi, H.G.; Park, E.S.; Lee, K.C.; Youn, Y.S. Doxorubicin-Bound Albumin Nanoparticles Containing a TRAIL Protein for Targeted Treatment of Colon Cancer. Pharm. Res., 2016, 33(3), 615-626.
[68]
Taheri, A.; Dinarvand, R.; Atyabi, F.; Ghahremani, M.H.; Ostad, S.N. Trastuzumab decorated methotrexate-human serum albumin conjugated nanoparticles for targeted delivery to HER2 positive tumor cells. Eur. J. Pharm. Sci., 2012, 47(2), 331-340.
[69]
Gong, G.; Pan, Q.; Wang, K.; Wu, R.; Sun, Y.; Lu, Y. Curcumin-incorporated albumin nanoparticles and its tumor image. Nanotechnology, 2015, 26(4), 045603.
[70]
Watcharin, W.; Schmithals, C.; Pleli, T.; Köberle, V.; Korkusuz, H.; Hübner, F.; Waidmann, O.; Zeuzem, S.; Korf, H.W.; Terfort, A.; Gelperina, S.; Vogl, T.J.; Kreuter, J.; Piiper, A. Detection of hepatocellular carcinoma in transgenic mice by Gd-DTPA- and rhodamine 123-conjugated human serum albumin nanoparticles in T1 magnetic resonance imaging. J. Control. Release, 2015, 199, 63-71.
[71]
Mertz, D.; Affolter-Zbaraszczuk, C.; Barthès, J.; Cui, J.; Caruso, F.; Baumert, T.F.; Voegel, J.C.; Ogier, J.; Meyer, F. Templated assembly of albumin-based nanoparticles for simultaneous gene silencing and magnetic resonance imaging. Nanoscale, 2014, 6(20), 11676-11680.
[72]
Elsadek, B.; Kratz, F. Impact of albumin on drug delivery--new applications on the horizon. J. Control. Release, 2012, 157(1), 4-28.
[73]
Larsen, M.T.; Kuhlmann, M.; Hvam, M.L.; Howard, K.A. Albumin-based drug delivery: harnessing nature to cure disease. Mol. Cell. Ther., 2016, 4, 3.
[74]
Sethi, A.; Sher, M.; Akram, M.R.; Karim, S.; Khiljee, S.; Sajjad, A.; Shah, S.N.H.; Murtaza, G. Albumin as a drug delivery and diagnostic tool and its market approved products. Acta Pol. Pharm., 2013, 70(4), 597-600.
[75]
Hawkins, M.J.; Soon-Shiong, P.; Desai, N. Protein nanoparticles as drug carriers in clinical medicine. Adv. Drug Deliv. Rev., 2008, 60(8), 876-885.
[76]
Wang, Y.; Lang, L.; Huang, P.; Wang, Z.; Jacobson, O.; Kiesewetter, D.O.; Ali, I.U.; Teng, G.; Niu, G.; Chen, X. In vivo albumin labeling and lymphatic imaging. Proc. Natl. Acad. Sci. USA, 2015, 112(1), 208-213.
[77]
Buckle, T.; van Leeuwen, A.C.; Chin, P.T.; Janssen, H.; Muller, S.H.; Jonkers, J.; van Leeuwen, F.W. A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. Nanotechnology, 2010, 21(35), 355101.
[78]
Kang, C.M.; An, G.I.; Choe, Y.S. Hybrid lymph node imaging using 64Cu-labeled mannose-conjugated human serum albumin with and without indocyanine green. Nucl. Med. Commun., 2015, 36(10), 1026-1034.
[79]
Kanazaki, K.; Sano, K.; Makino, A.; Takahashi, A.; Deguchi, J.; Ohashi, M.; Temma, T.; Ono, M.; Saji, H. Development of human serum albumin conjugated with near-infrared dye for photoacoustic tumor imaging. J. Biomed. Opt., 2014, 19(9), 96002.
[80]
Sheng, Z.; Hu, D.; Zheng, M.; Zhao, P.; Liu, H.; Gao, D.; Gong, P.; Gao, G.; Zhang, P.; Ma, Y.; Cai, L. Smart human serum albumin-indocyanine green nanoparticles generated by programmed assembly for dual-modal imaging-guided cancer synergistic phototherapy. ACS Nano, 2014, 8(12), 12310-12322.
[81]
Chen, Q.; Wang, X.; Wang, C.; Feng, L.; Li, Y.; Liu, Z. Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy. ACS Nano, 2015, 9(5), 5223-5233.
[82]
Lin, X.; Xie, J.; Niu, G.; Zhang, F.; Gao, H.; Yang, M.; Quan, Q.; Aronova, M.A.; Zhang, G.; Lee, S.; Leapman, R.; Chen, X. Chimeric ferritin nanocages for multiple function loading and multimodal imaging. Nano Lett., 2011, 11(2), 814-819.
[83]
Wang, Z.; Huang, P.; Jacobson, O.; Wang, Z.; Liu, Y.; Lin, L.; Lin, J.; Lu, N.; Zhang, H.; Tian, R.; Niu, G.; Liu, G.; Chen, X. Biomineralization-Inspired Synthesis of Copper Sulfide-Ferritin Nanocages as Cancer Theranostics. ACS Nano, 2016, 10(3), 3453-3460.
[84]
Huang, P.; Rong, P.; Jin, A.; Yan, X.; Zhang, M.G.; Lin, J.; Hu, H.; Wang, Z.; Yue, X.; Li, W.; Niu, G.; Zeng, W.; Wang, W.; Zhou, K.; Chen, X. Dye-loaded ferritin nanocages for multimodal imaging and photothermal therapy. Adv. Mater., 2014, 26(37), 6401-6408.
[85]
Liang, M.; Fan, K.; Zhou, M.; Duan, D.; Zheng, J.; Yang, D.; Feng, J.; Yan, X. H-ferritin-nanocaged doxorubicin nanoparticles specifically target and kill tumors with a single-dose injection. Proc. Natl. Acad. Sci. USA, 2014, 111(41), 14900-14905.
[86]
Yang, Z.; Wang, X.; Diao, H.; Zhang, J.; Li, H.; Sun, H.; Guo, Z. Encapsulation of platinum anticancer drugs by apoferritin. Chem. Commun. (Camb.), 2007, 33(33), 3453-3455.
[87]
Zhen, Z.; Tang, W.; Chen, H.; Lin, X.; Todd, T.; Wang, G.; Cowger, T.; Chen, X.; Xie, J. RGD-modified apoferritin nanoparticles for efficient drug delivery to tumors. ACS Nano, 2013, 7(6), 4830-4837.
[88]
Zhen, Z.; Tang, W.; Guo, C.; Chen, H.; Lin, X.; Liu, G.; Fei, B.; Chen, X.; Xu, B.; Xie, J. Ferritin nanocages to encapsulate and deliver photosensitizers for efficient photodynamic therapy against cancer. ACS Nano, 2013, 7(8), 6988-6996.
[89]
He, D.; Marles-Wright, J. Ferritin family proteins and their use in bionanotechnology. N. Biotechnol., 2015, 32(6), 651-657.
[90]
Fan, K.; Cao, C.; Pan, Y.; Lu, D.; Yang, D.; Feng, J.; Song, L.; Liang, M.; Yan, X. Magnetoferritin nanoparticles for targeting and visualizing tumour tissues. Nat. Nanotechnol., 2012, 7(7), 459-464.
[91]
Zhao, Y.; Liang, M.; Li, X.; Fan, K.; Xiao, J.; Li, Y.; Shi, H.; Wang, F.; Choi, H.S.; Cheng, D.; Yan, X. Bioengineered Magnetoferritin Nanoprobes for Single-Dose Nuclear-Magnetic Resonance Tumor Imaging. ACS Nano, 2016, 10(4), 4184-4191.
[92]
Sana, B.; Poh, C.L.; Lim, S. A manganese-ferritin nanocomposite as an ultrasensitive T2 contrast agent. Chem. Commun. (Camb.), 2012, 48(6), 862-864.
Call for Papers in Thematic Issues
31 December, 2024
Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.
The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more
31 December, 2024
Approaches to the treatment of chronic inflammation
Chronic inflammation is a hallmark of numerous diseases, significantly impacting global health. Although chronic inflammation is a hot topic, not much has been written about approaches to its treatment. This thematic issue aims to showcase the latest advancements in chronic inflammation treatment and foster discussion on future directions in this ...read more
10 November, 2024
Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications
The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more
30 September, 2024
Chalcogen-modified nucleic acid analogues
Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Analytical Chemistry
Current Computer-Aided Drug Design
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Diabetes Reviews
Current Drug Safety
Related Books
Infectious Diseases
Advances in Dye Degradation
The Chemistry inside Spices & Herbs: Research and Development
The Chemistry inside Spices & Herbs: Research and Development
Emerging Approaches to Tackle Neglected Diseases: From Molecule to End Product
Indicator Displacement Assays (IDAs): An Innovative Molecular Sensing Approach
Drug Addiction Mechanisms in the Brain
The NLRP3 Inflammasome: An Attentive Arbiter of Inflammatory Response
Botanicals and Natural Bioactives: Prevention and Treatment of Diseases
Software and Programming Tools in Pharmaceutical Research
Article Metrics
86
13
1
2